Vanguard Capital Management Establishes 5% Stake in PROCEPT BioRobotics Corp

Vanguard Capital Management LLC filed a Schedule 13G on April 30, 2026, reporting a new 5.0% ownership stake in PROCEPT BioRobotics Corp (PRCT). As of the event date of March 31, 2026, the firm beneficially owns 2,820,430 shares of common stock. This represents a significant increase from its previously reported 0.0% position. The filing indicates that Vanguard holds sole dispositive power over all 2,820,430 shares, while maintaining sole voting power over 421,363 shares. The securities were acquired in the ordinary course of business and not for the purpose of influencing or changing the control of the issuer. The reported holdings include shares managed by various Vanguard affiliates, including Vanguard Asset Management Limited and Vanguard Global Advisers, LLC. No other single person's interest in these securities exceeds 5% of the total class. PROCEPT BioRobotics is a San Jose-based medical technology company, and this filing marks Vanguard's emergence as a major institutional shareholder.